Suppr超能文献

[ε-氨基己酸治疗早产儿严重且占主导地位的高纤维蛋白溶解症]

[Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant].

作者信息

Schmidt B, Pringsheim W, Künzer W

出版信息

Helv Paediatr Acta. 1980 Jul;35(3):273-9.

PMID:6773909
Abstract

A premature infant of 31 weeks gestational age weighing 1650 g developed pronounced generalized bleeding following exchange transfusion for rhesus-incompatibility. As a consequence there was continuous leakage into a subcutaneous haematoma that had been caused by accidental puncture of the infant's flank during diagnostic amniocentesis. The ensuing massive and prolonged loss of blood required replacement by infusions of heparinized fresh blood over several days. The most conspicuous detail in the longitudinal study of haemostasis was hyperfibrinolysis with values for Fibrin-Fibrinogen Split Products exceeding 1280 micrograms/ml. This situation could be treated effectively with epsilon-amino-capronic acid. We suggest that anti-fibrinolytic agents can be recommended under cover of heparin for treating those rare cases in which hyperfibrinolysis predominates and clinical criteria of disseminated intravascular thrombosis are missing. We would, however, strongly discourage the uncritical use of antifibrinolytic agents whenever Fibrin-Fibrinogen-Split Products are detected.

摘要

一名孕31周、体重1650克的早产儿因恒河猴血型不相容进行换血治疗后,出现明显的全身性出血。结果,血液持续渗入皮下血肿,该血肿是在诊断性羊膜穿刺术期间意外穿刺婴儿侧腹所致。随后大量且持续的失血需要在数天内输注肝素化新鲜血液来补充。在止血的纵向研究中,最显著的细节是纤维蛋白溶解亢进,纤维蛋白 - 纤维蛋白原裂解产物的值超过1280微克/毫升。这种情况可用ε - 氨基己酸有效治疗。我们建议,在肝素的掩护下,抗纤维蛋白溶解剂可用于治疗那些罕见的、以纤维蛋白溶解亢进为主且缺乏弥散性血管内血栓形成临床标准的病例。然而,只要检测到纤维蛋白 - 纤维蛋白原裂解产物,我们强烈反对不加区分地使用抗纤维蛋白溶解剂。

相似文献

6
Amicar and hyperfibrinolysis.
Med Lett Drugs Ther. 1967 Jan 10;9(3):10-1.
10
[Hyperfibrinolysis].
Hoppe Seylers Z Physiol Chem. 1968 Jul;349(7):934-5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验